Harada Naozumi CEO, United Immunity Transforming Cancer Immunotherapy by Utilizing a Novel Tumor-Associated Macrophage-Selective Nanoparticulate Delivery System
Online matchmaking and meeting tool on B2B platform have already been available since 1 November! To fully exploit business opportunities in this enormous market, please go to our B2B website for more products and services.